Asthma-COPD Overlap and Chronic Airflow Obstruction: Definitions, Management, and Unanswered Questions

Adeloye, 2015, Global and regional estimates of COPD prevalence: systematic review and meta-analysis, J Glob Health, 5, 020415 To, 2012, Global asthma prevalence in adults: findings from the cross-sectional world health survey, BMC Public Health, 12, 204, 10.1186/1471-2458-12-204 Barnes, 2000, Mechanisms in COPD: differences from asthma, Chest, 117, 10S, 10.1378/chest.117.2_suppl.10S Turner-Warwick, 1977, On observing patterns of airflow obstruction in chronic asthma, Br J Dis Chest, 71, 73, 10.1016/0007-0971(77)90086-9 Bennett, 2018, Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma, Ann Allergy Asthma Immunol, 120, 164, 10.1016/j.anai.2017.10.004 Ulrik, 1999, Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma, Eur Respir J, 14, 892, 10.1034/j.1399-3003.1999.14d27.x Vogelmeier, 2017, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary, Eur Respir J, 49, 10.1183/13993003.00214-2017 Kaminska, 2009, Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction, J Allergy Clin Immunol, 124, 45, 10.1016/j.jaci.2009.03.049 Fabbri, 2003, Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 167, 418, 10.1164/rccm.200203-183OC Lee, 2007, Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study, Chest, 132, 1882, 10.1378/chest.07-0713 Gelb, 2000, Unsuspected pseudophysiologic emphysema in chronic persistent asthma, Am J Respir Crit Care Med, 162, 1778, 10.1164/ajrccm.162.5.2001037 Bumbacea, 2004, Parameters associated with persistent airflow obstruction in chronic severe asthma, Eur Respir J, 24, 122, 10.1183/09031936.04.00077803 Connolly, 1988, The relationship between age and duration of asthma and the presence of persistent obstruction in asthma, Postgrad Med J, 64, 422, 10.1136/pgmj.64.752.422 Contoli, 2010, Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up, J Allergy Clin Immunol, 125, 830, 10.1016/j.jaci.2010.01.003 Panizza, 2006, Mortality and airflow obstruction in asthma: a 17-year follow-up study, Intern Med J, 36, 773, 10.1111/j.1445-5994.2006.01214.x Vonk, 2003, Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up, Thorax, 58, 322, 10.1136/thorax.58.4.322 Tashkin, 2014, Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses, J Asthma, 51, 603, 10.3109/02770903.2014.895012 Chang, 2014, Childhood asthma clusters and response to therapy in clinical trials, J Allergy Clin Immunol, 133, 363, 10.1016/j.jaci.2013.09.002 Fitzpatrick, 2011, Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program, J Allergy Clin Immunol, 127, 382, 10.1016/j.jaci.2010.11.015 Postma, 2015, Revisiting the Dutch hypothesis, J Allergy Clin Immunol, 136, 521, 10.1016/j.jaci.2015.06.018 Barrecheguren, 2015, Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?, Int J Chron Obstruct Pulmon Dis, 10, 1745 Hardin, 2011, The clinical features of the overlap between COPD and asthma, Respir Res, 12, 127, 10.1186/1465-9921-12-127 Miravitlles, 2013, Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status, Respir Med, 107, 1053, 10.1016/j.rmed.2013.03.007 Bai, 2017, Asthma-COPD overlap syndrome showed more exacerbations however lower mortality than COPD, QJM, 110, 431 Menezes, 2014, Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma, Chest, 145, 297, 10.1378/chest.13-0622 Pellegrino, 2005, Interpretative strategies for lung function tests, Eur Respir J, 26, 948, 10.1183/09031936.05.00035205 Cosio, 2017, Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?, Eur Respir J, 49, 1602397, 10.1183/13993003.02397-2016 Cosio, 2016, Defining the asthma-COPD overlap syndrome in a COPD cohort, Chest, 149, 45, 10.1378/chest.15-1055 Sin, 2016, What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion, Eur Respir J, 48, 664, 10.1183/13993003.00436-2016 Barczyk, 2019, Asthma-COPD overlap—a discordance between patient populations defined by different diagnostic criteria, J Allergy Clin Immunol Pract, 7, 2326, 10.1016/j.jaip.2019.04.022 de Marco, 2013, The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population, PLoS One, 8, e62985, 10.1371/journal.pone.0062985 Henriksen, 2018, The prevalence and symptom profile of asthma-COPD overlap: the HUNT study, COPD, 15, 27, 10.1080/15412555.2017.1408580 Kumbhare, 2016, Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States, Ann Am Thorac Soc, 13, 803, 10.1513/AnnalsATS.201508-554OC Marsh, 2008, Proportional classifications of COPD phenotypes, Thorax, 63, 761, 10.1136/thx.2007.089193 Alshabanat, 2015, Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis, PLoS One, 10, e0136065, 10.1371/journal.pone.0136065 Milanese, 2014, Asthma control in elderly asthmatics. An Italian observational study, Respir Med, 108, 1091, 10.1016/j.rmed.2014.05.016 Kiljander, 2015, Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study, NPJ Prim Care Respir Med, 25, 15047, 10.1038/npjpcrm.2015.47 Cazzola, 2016, Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?, J Allergy Clin Immunol, 138, 977, 10.1016/j.jaci.2016.04.028 de Marco, 2015, Asthma, COPD and overlap syndrome: a longitudinal study in young European adults, Eur Respir J, 46, 671, 10.1183/09031936.00008615 Park, 2018, Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort, Respir Res, 19, 36, 10.1186/s12931-018-0737-8 James, 2005, Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking, Am J Respir Crit Care Med, 171, 109, 10.1164/rccm.200402-230OC Pleasants, 2014, Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment, COPD, 11, 256 van Boven, 2016, Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life, Chest, 149, 1011, 10.1016/j.chest.2015.12.002 Diaz-Guzman, 2011, Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population, COPD, 8, 400, 10.3109/15412555.2011.611200 Fu, 2014, Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome, Respiration, 87, 63, 10.1159/000352053 Jenkins, 2019, Diagnosis and management of asthma, COPD and asthma-COPD overlap among primary care physicians and respiratory/allergy specialists: a global survey, Clin Respir J, 13, 355, 10.1111/crj.13016 Tashkin, 2016, Assessment of consistency of fixed airflow obstruction status during budesonide/formoterol treatment and its effects on treatment outcomes in patients with asthma, J Allergy Clin Immunol Pract, 4, 705, 10.1016/j.jaip.2016.02.014 Gjevre, 2006, The American Thoracic Society’s spirometric criteria alone is inadequate in asthma diagnosis, Can Respir J, 13, 433, 10.1155/2006/198940 Tashkin, 2008, Bronchodilator responsiveness in patients with COPD, Eur Respir J, 31, 742, 10.1183/09031936.00129607 Albert, 2012, Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease, Thorax, 67, 701, 10.1136/thoraxjnl-2011-201458 Nair, 2017, Airway hyperresponsiveness in asthma: measurement and clinical relevance, J Allergy Clin Immunol Pract, 5, 649, 10.1016/j.jaip.2016.11.030 Tashkin, 1992, The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group, Am Rev Respir Dis, 145, 301, 10.1164/ajrccm/145.2_Pt_1.301 Tkacova, 2016, Airway hyperresponsiveness in chronic obstructive pulmonary disease: a marker of asthma-chronic obstructive pulmonary disease overlap syndrome?, J Allergy Clin Immunol, 138, 1571, 10.1016/j.jaci.2016.04.022 Coates, 2017, ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests, Eur Respir J, 49, 1601526, 10.1183/13993003.01526-2016 Bafadhel, 2017, Eosinophils in COPD: just another biomarker?, Lancet Respir Med, 5, 747, 10.1016/S2213-2600(17)30217-5 Vedel-Krogh, 2016, Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study, Am J Respir Crit Care Med, 193, 965, 10.1164/rccm.201509-1869OC MacDonald, 2019, Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD, Chest, 156, 92, 10.1016/j.chest.2019.02.406 Barnes, 2016, Blood eosinophils as a marker of response to inhaled corticosteroids in COPD, Eur Respir J, 47, 1374, 10.1183/13993003.01370-2015 Hirai, 2017, A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype, Clin Exp Allergy, 47, 1374, 10.1111/cea.12970 Calverley, 2003, Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial, Lancet, 361, 449, 10.1016/S0140-6736(03)12459-2 Wedzicha, 2008, The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide, Am J Respir Crit Care Med, 177, 19, 10.1164/rccm.200707-973OC Wedzicha, 2016, Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD, N Engl J Med, 374, 2222, 10.1056/NEJMoa1516385 Lipson, 2018, Once-daily single-inhaler triple versus dual therapy in patients with COPD, N Engl J Med, 378, 1671, 10.1056/NEJMoa1713901 Kobayashi, 2016, Inflammatory biomarkers in asthma-COPD overlap syndrome, Int J Chron Obstruct Pulmon Dis, 11, 2117, 10.2147/COPD.S113647 Bousquet, 2010, Assessment of allergen sensitization in a general population-based survey (European Community Respiratory Health Survey I), Ann Epidemiol, 20, 797, 10.1016/j.annepidem.2010.05.012 Tamada, 2015, Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations, Int J Chron Obstruct Pulmon Dis, 10, 2169, 10.2147/COPD.S88274 Donohue, 2014, Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study, Int J Chron Obstruct Pulmon Dis, 9, 745, 10.2147/COPD.S44552 Chen, 2016, Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD, Int J Chron Obstruct Pulmon Dis, 11, 2385, 10.2147/COPD.S115378 Gibson, 2009, The overlap syndrome of asthma and COPD: what are its features and how important is it?, Thorax, 64, 728, 10.1136/thx.2008.108027 Miravitlles, 2017, Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines, Eur Respir J, 49, 1700068, 10.1183/13993003.00068-2017 Koblizek, 2017, Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study, Eur Respir J, 49, 1601446, 10.1183/13993003.01446-2016 Woodruff, 2017, American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop report, Am J Respir Crit Care Med, 196, 375, 10.1164/rccm.201705-0973WS Tan, 2015, Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study, Thorax, 70, 822, 10.1136/thoraxjnl-2015-206938 Doiron, 2019, Air pollution, lung function and COPD: results from the population-based UK Biobank study, Eur Respir J, 54, 1802140, 10.1183/13993003.02140-2018 Eisner, 2005, Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease, Environ Health, 4, 7, 10.1186/1476-069X-4-7 Jaakkola, 2003, Environmental tobacco smoke and adult-onset asthma: a population-based incident case-control study, Am J Public Health, 93, 2055, 10.2105/AJPH.93.12.2055 Suissa, 2000, Low-dose inhaled corticosteroids and the prevention of death from asthma, N Engl J Med, 343, 332, 10.1056/NEJM200008033430504 Fingleton, 2015, Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults, J Allergy Clin Immunol, 136, 601, 10.1016/j.jaci.2015.01.013 Lee, 2016, Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome, Int J Chron Obstruct Pulmon Dis, 11, 2797, 10.2147/COPD.S114964 Su, 2018, Use of ICS/LABA combinations or LAMA is associated with a lower risk of acute exacerbation in patients with coexistent COPD and asthma, J Allergy Clin Immunol Pract, 6, 1927, 10.1016/j.jaip.2018.01.035 Lim, 2014, Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome, Ann Allergy Asthma Immunol, 113, 652, 10.1016/j.anai.2014.08.021 Chowdhury, 2010, The FDA and safe use of long-acting beta-agonists in the treatment of asthma, N Engl J Med, 362, 1169, 10.1056/NEJMp1002074 Gershon, 2014, Combination long-acting beta-agonists and inhaled corticosteroids compared with long-acting beta-agonists alone in older adults with chronic obstructive pulmonary disease, JAMA, 312, 1114, 10.1001/jama.2014.11432 Crim, 2009, Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results, Eur Respir J, 34, 641, 10.1183/09031936.00193908 O’Byrne, 2011, Risks of pneumonia in patients with asthma taking inhaled corticosteroids, Am J Respir Crit Care Med, 183, 589, 10.1164/rccm.201005-0694OC Vedel-Krogh, 2018, Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD, Eur Respir J, 51, 1800120, 10.1183/13993003.00120-2018 Pavord, 2016, Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis, Lancet Respir Med, 4, 731, 10.1016/S2213-2600(16)30148-5 Kew, 2014, Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis, Cochrane Database Syst Rev, CD010844 Kerstjens, 2012, Tiotropium in asthma poorly controlled with standard combination therapy, N Engl J Med, 367, 1198, 10.1056/NEJMoa1208606 Magnussen, 2008, Improvements with tiotropium in COPD patients with concomitant asthma, Respir Med, 102, 50, 10.1016/j.rmed.2007.08.003 Ishiura, 2019, Effect of triple therapy in patients with asthma-COPD overlap, Int J Clin Pharmacol Ther, 57, 384, 10.5414/CP203382 Yoshida, 2013, Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes, Pulm Pharmacol Ther, 26, 159, 10.1016/j.pupt.2012.09.007 Albert, 2011, Azithromycin for prevention of exacerbations of COPD, N Engl J Med, 365, 689, 10.1056/NEJMoa1104623 Rahimi, 2019, Urgent action on antimicrobial resistance, Lancet Respir Med, 7, 208, 10.1016/S2213-2600(19)30031-1 Gibson, 2017, Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial, Lancet, 390, 659, 10.1016/S0140-6736(17)31281-3 Normansell, 2014, Omalizumab for asthma in adults and children, Cochrane Database Syst Rev, CD003559 Tat, 2016, Omalizumab treatment in asthma-COPD overlap syndrome, J Asthma, 53, 1048, 10.1080/02770903.2016.1178281 Maltby, 2017, Omalizumab treatment response in a population with severe allergic asthma and overlapping COPD, Chest, 151, 78, 10.1016/j.chest.2016.09.035 Castro, 2018, Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma, N Engl J Med, 378, 2486, 10.1056/NEJMoa1804092 Ortega, 2014, Mepolizumab treatment in patients with severe eosinophilic asthma, N Engl J Med, 371, 1198, 10.1056/NEJMoa1403290 FitzGerald, 2016, Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial, Lancet, 388, 2128, 10.1016/S0140-6736(16)31322-8 Criner, 2019, Benralizumab for the prevention of COPD exacerbations, N Engl J Med, 381, 1023, 10.1056/NEJMoa1905248 Pavord, 2017, Mepolizumab for eosinophilic chronic obstructive pulmonary disease, N Engl J Med, 377, 1613, 10.1056/NEJMoa1708208 Agusti, 2016, Treatable traits: toward precision medicine of chronic airway diseases, Eur Respir J, 47, 410, 10.1183/13993003.01359-2015 Kitaguchi, 2012, Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma, Int J Chron Obstruct Pulmon Dis, 7, 283 Fishman, 2003, A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema, N Engl J Med, 348, 2059, 10.1056/NEJMoa030287 Davey, 2015, Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial, Lancet, 386, 1066, 10.1016/S0140-6736(15)60001-0 Mainardi, 2019, Bronchial thermoplasty, Clin Chest Med, 40, 193, 10.1016/j.ccm.2018.10.015 Burn, 2019, Efficacy and safety of bronchial thermoplasty in clinical practice: a prospective, longitudinal, cohort study using evidence from the UK Severe Asthma Registry, BMJ Open, 9, e026742, 10.1136/bmjopen-2018-026742 Doeing, 2013, Safety and feasibility of bronchial thermoplasty in asthma patients with very severe fixed airflow obstruction: a case series, J Asthma, 50, 215, 10.3109/02770903.2012.751997 Adams, 2002, Intranasal steroids and the risk of emergency department visits for asthma, J Allergy Clin Immunol, 109, 636, 10.1067/mai.2002.123237 Callebaut, 2013, Effect of nasal anti-inflammatory treatment in chronic obstructive pulmonary disease, Am J Rhinol Allergy, 27, 273, 10.2500/ajra.2013.27.3887 Georgalas, 2014, Evidence-based surgery for chronic rhinosinusitis with and without nasal polyps, Curr Allergy Asthma Rep, 14, 427, 10.1007/s11882-014-0427-7 Dixon, 2011, Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation, J Allergy Clin Immunol, 128, 508, 10.1016/j.jaci.2011.06.009 Goto, 2018, Reduced risk of acute exacerbation of COPD after bariatric surgery: a self-controlled case series study, Chest, 153, 611, 10.1016/j.chest.2017.07.003 McCarthy, 2015, Pulmonary rehabilitation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003793 Conemans, 2018, Effects of pulmonary rehabilitation in patients with asthma, Eur Respir J, 52, PA2043 Chaudhuri, 2006, Effects of smoking cessation on lung function and airway inflammation in smokers with asthma, Am J Respir Crit Care Med, 174, 127, 10.1164/rccm.200510-1589OC Tønnesen, 2005, Effects of smoking cessation and reduction in asthmatics, Nicotine Tob Res, 7, 139, 10.1080/14622200412331328411 Godtfredsen, 2008, COPD-related morbidity and mortality after smoking cessation: status of the evidence, Eur Respir J, 32, 844, 10.1183/09031936.00160007 Dalal, 2011, Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population, COPD, 8, 293, 10.3109/15412555.2011.586659 Paz-Díaz, 2007, Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD, Am J Phys Med Rehabil, 86, 30, 10.1097/PHM.0b013e31802b8eca Hynninen, 2017, Non-pharmacological interventions to manage depression and anxiety associated with chronic respiratory diseases: cognitive behavioral therapy and others, 149 Yohannes, 2017, Pharmacological therapy and anxiolytics in patients with respiratory diseases, 167 McDonald, 2011, Multidimensional assessment of older people with asthma and COPD: clinical management and health status, Age Ageing, 40, 42, 10.1093/ageing/afq134